tiprankstipranks
Trending News
More News >
Oxford BioMedica plc (GB:OXB)
LSE:OXB
UK Market

Oxford BioMedica (OXB) Income Statement

Compare
65 Followers

Oxford BioMedica Income Statement

Last quarter (Q4 2024), Oxford BioMedica's total revenue was £77.99M, an increase of 2.67% from the same quarter last year. In Q4, Oxford BioMedica's net income was £-10.71M. See Oxford BioMedica’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 128.80M£ 89.54M£ 139.99M£ 142.80M£ 87.73M
Gross Profit
£ 53.02M£ 39.73M£ 69.18M£ 82.64M£ 46.07M
Operating Expenses
£ 92.40M£ 223.90M£ 120.74M£ 61.71M£ 50.94M
Depreciation and Amortization
£ 23.09M£ 28.71M£ 26.43M£ 12.46M£ 9.62M
EBITDA
£ -14.33M£ -148.62M£ -10.86M£ 33.22M£ 3.92M
Operating Income
£ -39.38M£ -184.17M£ -51.56M£ 20.77M£ -4.83M
Other Income/Expenses
£ -7.89M£ -4.35M£ -15.76M£ -888.00K£ -878.00K
Pretax Income
£ -47.27M£ -188.53M£ -45.98M£ 19.88M£ -6.57M
Net Income
£ -43.19M£ -157.49M£ -45.16M£ 19.01M£ -6.25M
Per Share Metrics
Basic EPS
£ -0.42£ -1.63£ -0.48£ 0.23£ -0.08
Diluted EPS
£ -0.42£ -1.63£ -0.48£ 0.22£ -0.08
Weighted Average Shares Outstanding
103.46M 96.56M 94.83M 83.48M 79.94M
Weighted Average Shares Outstanding (Diluted)
103.46M 96.56M 94.83M 85.62M 79.94M
Currency in GBP

Oxford BioMedica Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis